Iron deficiency remains a significant problem for pregnant women in the UK. The objective of these guidelines is to provide healthcare professionals with recommendations for the prevention, diagnosis and treatment of iron deficiency in pregnancy and in the postpartum period. The guidelines update and replace the previous ones (Pavord et al, 2012). The prevalence of anaemia in pregnancy remains high. In order to minimise adverse outcomes, including use of blood transfusion, further research is required to define optimal management, as many current recommendations are not supported by high quality evidence.
Correction: Table III Summary of intravenous iron preparations available in the UK (Page 7)
Column 4 bottom row has two 0's missing
The column for Iron Carboxymaltose, currently states that the Risk of anaphylactoid reaction >1/1000 <1/100 whereas it should say Risk of anaphylactoid reaction >1/10,000 <1/1000 i.e. there is a 0 missing from both numbers.
Audio commentary of the full guideline by Sue Pavord coming soon.
Declaration of Interests
The BSH paid the expenses incurred during the writing of this guidance. None of the authors had conflicts of interest to declare. All authors have made a declaration of interests to the BSH and Task Force Chairs which may be viewed on request.